Table 5.
LCD status | |||
---|---|---|---|
OR (95%CI) | β ± SE | P | |
Evening type* | |||
Intermediate | |||
IL-1β | 0.33 (0.02–4.49) | − 1.10 ± 1.33 | 0.67 |
Galectin-3 | 0.21 (0.02–2.06) | − 1.52 ± 1.14 | 0.18 |
TGF-β | 0.12 (0.03–0.47) | − 2.12 ± 0.69 | 0.004 |
Morning type | |||
IL-1β | 0.36 (0.02–6.04) | − 1 ± 1.46 | 0.49 |
Galectin-3 | 0.17 (0.01–1.95) | − 1.76 ± 1.24 | 0.4 |
TGF-β | 0.11 (0.02–0.53) | − 2.13 ± 0.77 | 0.002 |
OR, Odds ratio; CI, confidence interval; SE, standard error; Il-1β, Interleukin-1β; TGF-β, Transforming growth factor β; N: 304; Multinominal logistic regression adjusted model to job, fat free mass, physical activity, stress as covariates in addition to the inflammatory markers
*Consider as reference